Becoming adherent to a preventive treatment for HIV: a qualitative approach

References

• Bachanas, P., Medeley, A., & Pals, S. (2013). Disclosure knowledge of partner status and condom use among HIV-positive patients attending clinical care in Tanzania, Kenya and Namibia. AIDS Patient Care and STDs, 27(7), 425–435.
   PubMed Web of Science ®Google Scholar
• Bardin, L. (1977). L’analyse de contenu, Paris: Presses Universitaires de France.
   Google Scholar
• Barofsky, I. (1978). Compliance, adherence and the therapeutic alliance: Steps in the development of self-care. Social Science & Medicine Part A: Medical Psychology & Medical Sociology, 12, 369–376.
   Google Scholar
• Blashill, A. J., Ehlinger, P. P., Mayer, K. H., & Safren, S. A. (2015). Optimizing adherence to preexposure and postexposure prophylaxis: The need for an integrated biobehavioral approach. Clinical Infectious Diseases, 60(3), 187–190.
   Google Scholar
• Chang, L. W., Serwadda, D., Quinn, T. C., Wawer, M. J., Gray, R. H., & Reynolds, S. J. (2013). Combination implementation for HIV prevention: Moving from evidence to population-level impact. The Lancet Infectious Diseases, 13(1), 65–76.
   PubMed Web of Science ®Google Scholar
• Clifford, S. (2008). Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: Application of the necessity-concerns framework. Journal of Psychosomatic Research, 64(1). doi:10.1016/j.jpsychores.2007.05.004
   PubMed Web of Science ®Google Scholar
• Collin, J., & David, P.-M. (2016). Vers une pharmaceuticalisation de la société.Le médicament comme objet social. Quebec: Presse de l’Université du Quebec.
   Google Scholar
• Conrad, P. (1985). The meaning of medications: Another look at compliance. The Sociology of Health and Illness, 20(1), 29–37.
   Google Scholar
• Danet, M. A., Coquelin, V., Quatremère, G., Suzan-Monti, M., & Spire, B., & Ipergay sexual health coaches’ team. (2015). Community-based support in the ANRS ipergay trial: Improving adherence to the trial and access to overall health. Presented at the 12th AIDS Impact International Conference, Amsterdam. Retrieved from http://www.aidsimpact.com/2015/Academics/DraftProgramme/abstract/?id=2275
   Google Scholar
• Desclaux, A., & Egrot, M. (2015). Anthropologie du médicament au sud : La pharmaceuticalisation à ses marges. Paris: L’Harmanattan.
   Google Scholar
• Foucault, M. (1975). Surveiller et punir - Naissance de la prison. Paris: Gallimard.
   Google Scholar
• Girard, G. (2016). “La pillule qui change tout”? Analyse des débats québécois autour de la prophylaxie pré-exposition du VIH. In J. Collin & P.-M. David (Eds.), Vers une pharmaceuticalisation de la société. Le médicament comme objet social (pp. 193–222). Quebec: Presse de l’Université du Quebec.
   Google Scholar
• Glaser, B. G., & Strauss, A. L. (1967). The discovery of grounded theory: Strategies for qualitative research. New York: Aldine.
   Google Scholar
• Goffman, E. (1963). Stigma: Notes on the management of a spoiled identity. Englewood Cliffs: Prentice-Hall Inc.
   Google Scholar
• Haire, B. (2015). Preexposure prophylaxis-related stigma: Strategies to improve uptake and adherence – A narrative review. HIV/AIDS – Research and Palliative Care, 7, 241–249.
   Google Scholar
• Herek, G. M. (2002). Thinking about AIDS and stigma: A psychologist’s perspective. The Journal of Law, Medicine & Ethics, 30(4), 594–607.
   PubMed Web of Science ®Google Scholar
• Hoff, C. C., Chakravarty, D., Bircher, A. E., Campbell, C. K., Grisham, K., & Neilands, T. B. (2015). Attitudes towards PrEP and anticipated condom use among concordant HIV-negative and HIV-discordant male couples. AIDS Patient Care and STDs, 29(7), 408–417.
   PubMed Web of Science ®Google Scholar
• Kalampalikis, N. (2004). Les focus groups, lieux d’ancrages. Bulletin De Psychologie, 57(3), 281–289.
   Google Scholar
• Kalichman, S. C. (2008). Association between health literacy and HIV treatment adherence: Further evidence from objectively measured medication adherence. Journal of the International Association of Physicians in AIDS Care, 7, 31.
   Google Scholar
• Kippax, S., & Stephenson, N. (2012). Beyond the distinction between biomedical and social dimensions of HIV prevention through the lens of a social public health. American Journal of Public Health, 102(5), 789–799.
   PubMed Web of Science ®Google Scholar
• Molina, J. M., Capitant, C., Spire, B., Pialoux, G., Cotte, L., Charreau, I., … Delfraissy, J.-F. (2015). On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. New England Journal of Medicine, 373(23), 2237–2246.
   PubMed Web of Science ®Google Scholar
• Molina, J. M., Charreau, I., Spire, B., Cotte, L., Chas, J., Capitant, C., … Meyer, L. (2017). Efficacy, safety and effect on sexual behaviout of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: On abservational cohort study. The Lancet HIV, 4(9), 402–410.
   PubMed Web of Science ®Google Scholar
• Molloy, G. J. (2012). Adherence to the oral contraceptive pill: A cross-sectional survey of modificable behavioural determinants. BCM Public Health, 12, 838.
   PubMed Web of Science ®Google Scholar
• Moreau, C., Bouyer, J., Gilbert, F., & Bajos, N. (2006). Social, demographic and situational characteristics associated with inconsistent use of oral contraceptives: Evidence from France. Perspectives on Sexual and Reproductive Health, 38(4), 190–196.
   PubMed Web of Science ®Google Scholar
• Nguyen, V.-K. (2011). Remedicalising an epidemic: From HIV treatment as prevention to HIV treatment is prevention. AIDS, 25(3), 291–293.
   PubMed Web of Science ®Google Scholar
• Paillé, P., & Mucchielli, A. (2012). L’analyse qualitative en sciences humaines et sociales. Paris: Armand Collin.
   Google Scholar
• Parsons, J. T. (2017). Uptake of HIV pre-exposure prophylaxis (PrEP) in a national cohort of gay and bisexual men in the United States. AIDS, 74(3), 285–292.
   Google Scholar
• Petryna, A. (2002). Life exposed: Biological citizens after chernobyl. Princeton: Princeton University Press.
   Google Scholar
• Pierret, J. (2006). Vivre avec le VIH. Enquête de longue durée auprès des personnes infectées. Paris: Presses Universitaires de France.
   Google Scholar
• Rabinow, P. (1994). The third culture. History of the Human Sciences, 7(2), 53–64.
   Google Scholar
• Sagaon-Teyssier, L., Suzan-Monti, M., Demoulin, B., Capitant, C., Lorente, N., & Préau, M. (2016). Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial. Aides Care, 28(1), 26–31.
   PubMed Web of Science ®Google Scholar
• Sagaon-Teyssier, L., Mabire, X., Laguette, V., Fressard, L., Suzan-Monti, M., Rojas Castro, D., … Molina, J.-M. (2018). A group-based trajectory model for changes in pre-exposure prophylaxis and condom use among men who have sex with men participating in the ANRS IPERGAY Trial. AIDS Patient Care and STDs, 32(12), 495–510.
   Web of Science ®Google Scholar
• Sarradon-Eck, A. (2007). Le sens de l’observance. Ethnographie des pratiques médicamenteuses de personnes hypertendues. Sciences Sociales Et Santé, 25(2), 5–36.
   Google Scholar
• Sarradon-Eck, A., Egrot, M., Blance, M. A., & Faure, M. (2010). Anthropological approach of adherence factors for antihypertensive drugs. Healthcare Policy, 5(4), e157–e175.
   PubMedGoogle Scholar
• Stuber, J., Meyer, I., & Link, B. (2008). Stigma, prejudice, discrimination and health. Social Science & Medicine, 67(3), 351.
   PubMed Web of Science ®Google Scholar
• Tourette-Turgis, C. (2007). La consultation d’aide à l’observance des traitements de l’infection à VIH. Paris: Comment Dire.
   Google Scholar
• Urquhart, J. (1997). The electronic medication event monitor. Lessons for pharmacotherapy. Clinical Pharmacokinetics, 32, 345–356.
   PubMed Web of Science ®Google Scholar
• Van der Geest, S., & Reynolds Whyte, S. (2003). Popularité et scepticisme : Opinions contrastées sur les médicaments. Anthropologie Et Sociétés, 27(2), 97–117.
   Google Scholar